Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback